Rapid Blood Test Can Improve Stroke Treatment

Blood Test

Key Takeaways

  • Blood testing could help people catch cancer early

  • Up to half of cancers could be caught at a more treatable stage

  • The blood test looks for DNA fragments shed by tumors and other markers of cancer

FRIDAY, May 9, 2025 (HealthDay News) — Blood tests could catch as many as half of cancers at an earlier, more treatable stage, a new study says.

If conducted every year or every other year, the multi-cancer early detection (MCED) blood test could help more people survive cancer, researchers reported May 8 in BMJ Open.

“Both annual and biennial MCED screening intervals have the potential to avert deaths associated with late-stage cancers when used in addition to current guideline-based cancer screening,” concluded a research team led by Peter Sasieni, a professor of cancer epidemiology  with Queen Mary University of London.

The blood test looks for many different cancer-specific signals, including DNA fragments shed by tumors, researchers said.

Only a few screenings today can reliably detect cancer among those at high risk, including tests for breast, colon, cervical and lung cancers, researchers said.

Blood testing offers an opportunity to detect dozens of different cancer types by looking for cancer markers in people’s bloodstream.

To estimate the usefulness of blood testing in regular cancer screening, researchers analyzed data from an earlier clinical trial that used the blood test to help diagnose cancer.

The analysis showed that blood testing improved early diagnosis for a wide variety of cancers.

Compared with standard cancer screening, annual blood testing was associated with 49% fewer late-stage cancer diagnoses and 21% fewer deaths within five years, results show.

Blood testing every other year resulted in 39% fewer late-stage diagnoses and 17% fewer deaths within five years, researchers added.

Among people diagnosed with an aggressive, fast-growing cancer, blood tests could avert 14% to 21% deaths within five years, results show.

“Based on the performance characteristics from a case control study, both annual and biennial screening with an MCED test have the potential to intercept 31% to 49% of cancers at stage 1-2 that would otherwise present at stage 3-4,” researchers estimate.

“Of these, approximately equal numbers would be detected at stage 1 and at stage 2,” they added.

These estimates assume complete compliance with screening schedules and follow-up testing, which is optimistic, researchers noted. They also assume that more early-stage diagnoses will automatically reduce death rates.

“The optimal choice of screening interval will depend on assessments of real-world cancer survival and the costs of confirmatory testing after MCED screening,” researchers said.

More information

The Cleveland Clinic has more on blood tests for cancer.

SOURCE: BMJ, news release, May 8, 2025

What This Means For You

In the future, regular blood screening might be implemented to help people catch cancer early.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.